| Food Products Industry | Consumer Staples Sector | Dr. Bing Yao CEO | XSHE Exchange | CNE100003K04 ISIN |
| CN Country | 2,487 Employees | 29 May 2025 Last Dividend | 25 Apr 2024 Last Split | - IPO Date |
CSPC Innovation Pharmaceutical Co., Ltd. is a comprehensive enterprise focusing on the research and development, production, and sales of a wide range of healthcare products, including biopharmaceuticals, Active Pharmaceutical Ingredients (APIs), and functional foods. The company operates both within China and internationally, reflecting its expansive footprint in the global pharmaceutical and health product markets. Established in 2006 and based in Shijiazhuang, China, CSPC Innovation Pharmaceutical stands as a crucial subsidiary of CSPC NBP Pharmaceutical Co., Ltd., underlining its pivotal role in the larger healthcare ecosystem. CSPC Innovation Pharmaceutical is dedicated to advancing healthcare solutions through innovation, quality production, and wide-ranging expertise in the pharmaceutical and food supplement sectors.